ORBIMED ADVISORS LLC Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$9.6B
Holdings
133
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (133 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ALKSALKERMES PLC | 172,000 | $7.4B | 77.57% | |
| 102 | —INCYTE CORP | 4,250,000 | $7.2B | 74.81% | |
| 103 | —INCYTE CORP | 4,250,000 | $7.1B | 73.62% | |
| 104 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,360,224 | $6.6B | 68.99% | |
| 105 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $6.1B | 64.05% | |
| 106 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $6.1B | 63.63% | |
| 107 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 724,184 | $5.9B | 61.59% | |
| 108 | BCRUSDBARD C R INC | 23,000 | $5.4B | 56.44% | |
| 109 | INFIQINFINITY PHARMACEUTICALS INC | 3,250,300 | $4.3B | 45.11% | |
| 110 | MGNXMACROGENICS INC | 149,400 | $4.0B | 42.07% | |
| 111 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $3.9B | 40.96% | |
| 112 | —ADVAXIS INC | 445,400 | $3.6B | 37.60% | |
| 113 | NVTA1EURINVITAE CORP | 456,666 | $3.4B | 35.22% | |
| 114 | NERVGBPMINERVA NEUROSCIENCES INC | 321,500 | $3.3B | 34.26% | |
| 115 | —PERNIX THERAPEUTICS HLDGS IN | 12,000,000 | $2.5B | 26.60% | |
| 116 | MCRB1EURSERES THERAPEUTICS INC | 86,000 | $2.5B | 26.07% | |
| 117 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $2.2B | 22.96% | |
| 118 | —ROKA BIOSCIENCE INC | 3,220,429 | $1.8B | 19.22% | |
| 119 | QUREUNIQURE NV | 195,400 | $1.4B | 15.03% | |
| 120 | —MARINUS PHARMACEUTICALS INC | 867,600 | $1.1B | 11.50% | |
| 121 | —MEDIGUS LTD | 600,000 | $1.1B | 11.40% | |
| 122 | AMEDAMEDISYS INC | 20,000 | $1.0B | 10.54% | |
| 123 | —COGENTIX MED INC | 990,745 | $953.0M | 9.94% | |
| 124 | —XTANT MED HLDGS INC | 475,439 | $908.0M | 9.48% | |
| 125 | —BIOLINERX LTD | 1,038,600 | $831.0M | 8.67% | |
| 126 | AMRNAMARIN CORP PLC | 350,000 | $756.0M | 7.89% | |
| 127 | —QLT INC | 500,000 | $710.0M | 7.41% | |
| 128 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $579.0M | 6.04% | |
| 129 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $555.0M | 5.79% | |
| 130 | —PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | $481.0M | 5.02% | |
| 131 | ONCBEIGENE LTD | 12,925 | $385.0M | 4.02% | |
| 132 | —ALIMERA SCIENCES INC | 250,000 | $308.0M | 3.21% | |
| 133 | —ARALEZ PHARMACEUTICALS INC | 68,143 | $225.0M | 2.35% |
PreviousPage 2 of 2